Skip to main content

Advertisement

Log in

Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels

  • Clinical Trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The potential advantage of using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) methodology to detect metastasis in sentinel lymph nodes (SLNs) of breast cancer (BC) patients was evaluated in this prospective study. We measured the expression of relevant gene transcripts in SLNs using an innovative algorithm and compared the results of single-marker assays versus multi-marker assays with conventional histological detection methods. SLNs from women aged ≥18 years diagnosed with unilateral BC were examined by haematoxylin-eosin staining and immunohistochemistry and analysed for transcripts of several relevant genes using qRT-PCR (learning group). Four candidate panels of expressed transcript combinations with high sensitivity and specificity were selected for further investigation. The candidate panels were then validated using SLNs from a second group of BC patients (validation group). In the learning group, 74/314 SLN sections from 150 patients were positive for metastasis by histology. The transcripts analysed showed the following individual sensitivities/specificities: cytokeratin 19 (CK19) 94.6%/97.9%; mammaglobin 1 (MGB1) 82.4%/91.7%; mammaglobin 2 (MGB2) 82.4%/96.7%; carcinoembryonic antigen (CEA) 71.6%/97.5%; EPCAM (epithelial cell adhesion molecule) 91.9%/97.1%; and NY-BR-1 82.4%/93.8%. The optimal panel based on the predefined criteria comprised four markers: CK19, MGB1, EPCAM, and NY-BR-1, of which ≥2 had to be positive (95.9% sensitivity, 95.0% specificity, 85.5% positive predictive value (PPV), and 98.7% negative predictive value (NPV)). Overall concordance with histology was 95.2%. In the validation group, 84/315 SLN sections from 235 patients were histologically positive, and panel sensitivity, specificity and overall accuracy were 88.1, 95.2 and 93.3%, respectively, at the SLN section level. In conclusion, molecular staging using expression patterns of relevant transcripts in SLNs could serve as a useful complement to standard diagnostic work-up in BC patients. The proposed flexible multi-parametric approach does not improve the overall accuracy compared with the single-marker approach. However, it overcomes several limitations of the previously reported molecular assays for SLN diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Cheng G, Kurita S, Torigian DA, Alavi A (2011) Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging 38(3):562–575. doi:10.1007/s00259-010-1577-z

    Article  PubMed  Google Scholar 

  2. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720. doi:10.1200/JCO.2005.08.001

    Article  PubMed  Google Scholar 

  3. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98(9):599–609. doi:10.1093/jnci/djj158

    Article  PubMed  Google Scholar 

  4. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE (2004) Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 40(11):1731–1737. doi:10.1016/j.ejca.2004.04.006

    Article  PubMed  CAS  Google Scholar 

  5. Cserni G, Gregori D, Merletti F, Sapino A, Mano MP, Ponti A, Sandrucci S, Baltas B, Bussolati G (2004) Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91(10):1245–1252. doi:10.1002/bjs.4725

    Article  PubMed  CAS  Google Scholar 

  6. Douglas-Jones AG, Woods V (2009) Molecular assessment of sentinel lymph node in breast cancer management. Histopathology 55(1):107–113. doi:10.1111/j.1365-2559.2008.03218.x

    Article  PubMed  Google Scholar 

  7. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252 (3):426–432; discussion 432–433. doi:10.1097/SLA.0b013e3181f08f32

    Google Scholar 

  8. Dowlatshahi K, Fan M, Anderson JM, Bloom KJ (2001) Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 8(8):675–681

    Article  PubMed  CAS  Google Scholar 

  9. Cserni G (2002) Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 55(12):926–931

    Article  PubMed  CAS  Google Scholar 

  10. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Fejes G, Wells CA (2004) Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 57(7):695–701. doi:10.1136/jcp.2003.013599

    Article  PubMed  CAS  Google Scholar 

  11. Nissan A, Jager D, Roystacher M, Prus D, Peretz T, Eisenberg I, Freund HR, Scanlan M, Ritter G, Old LJ, Mitrani-Rosenbaum S (2006) Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer 94(5):681–685. doi:10.1038/sj.bjc.6602992

    PubMed  CAS  Google Scholar 

  12. Chao C (2004) The use of frozen section and immunohistochemistry for sentinel lymph node biopsy in breast cancer. Am Surg 70(5):414–419

    PubMed  Google Scholar 

  13. Euhus DM (2003) Cytokeratin staining and other sentinel node controversies. Clin Breast Cancer 4(Suppl 1):S49–S54

    Article  PubMed  Google Scholar 

  14. Mitas M, Mikhitarian K, Walters C, Baron PL, Elliott BM, Brothers TE, Robison JG, Metcalf JS, Palesch YY, Zhang Z, Gillanders WE, Cole DJ (2001) Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 93(2):162–171. doi:10.1002/ijc.1312

    Article  PubMed  CAS  Google Scholar 

  15. Manzotti M, Dell’Orto P, Maisonneuve P, Zurrida S, Mazzarol G, Viale G (2001) Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer 95(5):307–312

    Article  PubMed  CAS  Google Scholar 

  16. Hughes SJ, Xi L, Raja S, Gooding W, Cole DJ, Gillanders WE, Mikhitarian K, McCarty K, Silver S, Ching J, McMillan W, Luketich JD, Godfrey TE (2006) A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg 243(3):389–398. doi:10.1097/01.sla.0000201541.68577.6a

    Article  PubMed  Google Scholar 

  17. Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, Walters C, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, Henderson MA, Dewitty RL, Sugg SL, Frykberg E, Yeh K, Bell RM, Metcalf JS, Elliott BM, Brothers T, Robison J, Mitas M, Cole DJ (2004) Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg 239(6):828–837 discussion 837–840

    Article  PubMed  Google Scholar 

  18. Mikhitarian K, Martin RH, Mitas M, Mauldin PD, Palesch Y, Metcalf JS, Cole DJ, Gillanders WE (2005) Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery 138(3):474–481. doi:10.1016/j.surg.2005.07.001

    Article  PubMed  Google Scholar 

  19. Backus J, Laughlin T, Wang Y, Belly R, White R, Baden J, Justus Min C, Mannie A, Tafra L, Atkins D, Verbanac KM (2005) Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn 7(3):327–336

    Article  PubMed  CAS  Google Scholar 

  20. Weigelt B, Verduijn P, Bosma AJ, Rutgers EJ, Peterse HL, van’t Veer LJ (2004) Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer 90(8):1531–1537. doi:10.1038/sj.bjc.6601659

    Article  PubMed  CAS  Google Scholar 

  21. Viale G, Dell’Orto P, Biasi MO, Stufano V, De Brito Lima LN, Paganelli G, Maisonneuve P, Vargo JM, Green G, Cao W, Swijter A, Mazzarol G (2008) Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg 247(1):136–142. doi:10.1097/SLA.0b013e318157d22b

    Article  PubMed  Google Scholar 

  22. R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org

  23. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222(3):394–399 discussion 399–401

    Article  PubMed  CAS  Google Scholar 

  24. Nwariaku FE, Euhus DM, Beitsch PD, Clifford E, Erdman W, Mathews D, Albores-Saavedra J, Leitch MA, Peters GN (1998) Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer. Am J Surg 176(6):529–531

    Article  PubMed  CAS  Google Scholar 

  25. Kissin MW, Querci della Rovere G, Easton D, Westbury G (1986) Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73(7):580–584

    Article  PubMed  CAS  Google Scholar 

  26. Roberts CA, Beitsch PD, Litz CE, Hilton DS, Ewing GE, Clifford E, Taylor W, Hapke MR, Babaian A, Khalid I, Hall JD, Lindberg G, Molberg K, Saboorian H (2003) Interpretive disparity among pathologists in breast sentinel lymph node evaluation. Am J Surg 186(4):324–329

    Article  PubMed  Google Scholar 

  27. den Bakker MA, van Weeszenberg A, de Kanter AY, Beverdam FH, Pritchard C, van der Kwast TH, Menke-Pluymers M (2002) Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 55(12):932–935

    Article  Google Scholar 

  28. Schoenfeld A, Luqmani Y, Smith D, O’Reilly S, Shousha S, Sinnett HD, Coombes RC (1994) Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54(11):2986–2990

    PubMed  CAS  Google Scholar 

  29. Abdul-Rasool S, Kidson SH, Panieri E, Dent D, Pillay K, Hanekom GS (2006) An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J Clin Pathol 59(3):289–297. doi:10.1136/jcp.2005.028357

    Article  PubMed  CAS  Google Scholar 

  30. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S, Koyama H (1994) The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 74(5):1595–1600

    Article  PubMed  CAS  Google Scholar 

  31. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DS (1998) Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16(8):2632–2640

    PubMed  CAS  Google Scholar 

  32. Daniele L, Annaratone L, Allia E, Mariani S, Armando E, Bosco M, Macri L, Cassoni P, D’Armento G, Bussolati G, Cserni G, Sapino A (2008) Technical limits of comparison of step-sectioning, immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn fixed tissue. J Cell Mol Med 13(9B):4042–4050. doi:10.1111/j.1582-4934.2008.00449.x

    Google Scholar 

  33. Dell’Orto P, Biasi MO, Del Curto B, Zurrida S, Galimberti V, Viale G (2006) Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA. Breast Cancer Res Treat 98(2):185–190. doi:10.1007/s10549-005-9148-x

    Article  PubMed  Google Scholar 

  34. Ouellette RJ, Richard D, Maicas E (2004) RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol 121(5):637–643. doi:10.1309/MMAC-TXT5-5L8Q-TKC1

    Article  PubMed  CAS  Google Scholar 

  35. Gould VE, Bloom KJ, Franke WW, Warren WH, Moll R (1995) Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression? Virchows Arch 425(6):617–629

    Article  PubMed  CAS  Google Scholar 

  36. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P (1995) Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 71(2):278–281

    Article  PubMed  CAS  Google Scholar 

  37. Bleiweiss IJ, Nagi CS, Jaffer S (2006) Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24(13):2013–2018. doi:10.1200/JCO.2005.04.7076

    Article  PubMed  Google Scholar 

  38. Ooka M, Sakita I, Fujiwara Y, Tamaki Y, Yamamoto H, Aihara T, Miyazaki M, Kadota M, Masuda N, Sugita Y, Iwao K, Monden M (2000) Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients. Oncol Rep 7(3):561–566

    PubMed  CAS  Google Scholar 

  39. Ruud P, Fodstad O, Hovig E (1999) Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 80(1):119–125

    Article  PubMed  CAS  Google Scholar 

  40. Gimbergues P, Dauplat MM, Cayre A, Durando X, Le Bouedec G, Finat-Duclos F, Portefaix G, Kwiatkowski F, Dauplat J, Penault-Llorca F, Tchirkov A (2007) Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category. Eur J Surg Oncol 33(1):16–22. doi:10.1016/j.ejso.2006.09.013

    Article  PubMed  CAS  Google Scholar 

  41. Blumencranz P, Whitworth PW, Deck K, Rosenberg A, Reintgen D, Beitsch P, Chagpar A, Julian T, Saha S, Mamounas E, Giuliano A, Simmons R (2007) Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 194(4):426–432. doi:10.1016/j.amjsurg.2007.07.008

    Article  PubMed  Google Scholar 

  42. Mansel RE, Goyal A, Douglas-Jones A, Woods V, Goyal S, Monypenny I, Sweetland H, Newcombe RG, Jasani B (2009) Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study. Breast Cancer Res Treat 115(3):595–600. doi:10.1007/s10549-008-0155-6

    Article  PubMed  Google Scholar 

  43. Visser M, Jiwa M, Horstman A, Brink AA, Pol RP, van Diest P, Snijders PJ, Meijer CJ (2008) Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer 122(11):2562–2567. doi:10.1002/ijc.23451

    Article  PubMed  CAS  Google Scholar 

  44. Tamaki Y, Akiyama F, Iwase T, Kaneko T, Tsuda H, Sato K, Ueda S, Mano M, Masuda N, Takeda M, Tsujimoto M, Yoshidome K, Inaji H, Nakajima H, Komoike Y, Kataoka TR, Nakamura S, Suzuki K, Tsugawa K, Wakasa K, Okino T, Kato Y, Noguchi S, Matsuura N (2009) Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res 15(8):2879–2884. doi:10.1158/1078-0432.CCR-08-1881

    Article  PubMed  CAS  Google Scholar 

  45. Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F, Kato Y, Tsuda H, Ueda S, Sato K, Tamaki Y, Noguchi S, Kataoka TR, Nakajima H, Komoike Y, Inaji H, Tsugawa K, Suzuki K, Nakamura S, Daitoh M, Otomo Y, Matsuura N (2007) One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 13(16):4807–4816. doi:10.1158/1078-0432.CCR-06-2512

    Article  PubMed  CAS  Google Scholar 

  46. Veys I, Majjaj S, Salgado R, Noterman D, Schobbens JC, Manouach F, Bourgeois P, Nogaret JM, Larsimont D, Durbecq V (2009) Evaluation of the histological size of the sentinel lymph node metastases using RT-PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-009-0555-2

  47. Schroder CP, Ruiters MH, de Jong S, Tiebosch AT, Wesseling J, Veenstra R, de Vries J, Hoekstra HJ, de Leij LF, de Vries EG (2003) Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes. Int J Cancer 106(4):611–618. doi:10.1002/ijc.11295

    Article  PubMed  Google Scholar 

  48. Inokuchi M, Ninomiya I, Tsugawa K, Terada I, Miwa K (2003) Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. Br J Cancer 89(9):1750–1756. doi:10.1038/sj.bjc.6601248

    Article  PubMed  CAS  Google Scholar 

  49. Diaz LK, Hunt K, Ames F, Meric F, Kuerer H, Babiera G, Ross M, Singletary E, Middleton LP, Symmans WF, Krishnamurthy S, Sahin A, Sneige N, Gilcrease MZ (2003) Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 27(3):385–389

    Article  PubMed  Google Scholar 

  50. Herbert GS, Sohn VY, Brown TA (2007) The impact of nodal isolated tumor cells on survival of breast cancer patients. Am J Surg 193(5):571–573. doi:10.1016/j.amjsurg.2007.01.007 discussion 573–574

    Article  PubMed  Google Scholar 

  51. Imoto S, Ochiai A, Okumura C, Wada N, Hasebe T (2006) Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining. Eur J Surg Oncol 32(10):1175–1179. doi:10.1016/j.ejso.2006.08.006

    Article  PubMed  CAS  Google Scholar 

  52. de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, Adang EM, Nortier JW, Rutgers EJ, Seynaeve C, Menke-Pluymers MB, Bult P, Tjan-Heijnen VC (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361(7):653–663. doi:10.1056/NEJMoa0904832

    Article  PubMed  Google Scholar 

  53. Hansen NM, Grube B, Ye X, Turner RR, Brenner RJ, Sim MS, Giuliano AE (2009) Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 27(28):4679–4684. doi:10.1200/JCO.2008.19.0686

    Article  PubMed  Google Scholar 

  54. Martin Martinez MD, Veys I, Majjaj S, Lespagnard L, Schobbens JC, Rouas G, Filippov V, Noterman D, Hertens D, Feoli F, Bourgeois P, Durbecq V, Larsimont D, Nogaret JM (2009) Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes. Eur J Surg Oncol 35(4):387–392. doi:10.1016/j.ejso.2008.05.008

    Article  PubMed  CAS  Google Scholar 

  55. Carter BA, Jensen RA, Simpson JF, Page DL (2000) Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 113(2):259–265. doi:10.1309/7EF8-F1W7-YVNT-H8H5

    Article  PubMed  CAS  Google Scholar 

  56. Diaz NM, Vrcel V, Centeno BA, Muro-Cacho C (2005) Modes of benign mechanical transport of breast epithelial cells to axillary lymph nodes. Adv Anat Pathol 12(1):7–9

    Article  PubMed  Google Scholar 

  57. Julian TB, Blumencranz P, Deck K, Whitworth P, Berry DA, Berry SM, Rosenberg A, Chagpar AB, Reintgen D, Beitsch P, Simmons R, Saha S, Mamounas EP, Giuliano A (2008) Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol 26(20):3338–3345. doi:10.1200/JCO.2007.14.0665

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Simone Fomuki, Heidelberg, for the excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Markus Wallwiener.

Additional information

Christian W. Wallwiener and Markus Wallwiener are joint authors and equal contributors.

Thomas Giese and Tanja N. Fehm are equally contributing senior authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wallwiener, C.W., Wallwiener, M., Kurth, R.R. et al. Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels. Breast Cancer Res Treat 130, 833–844 (2011). https://doi.org/10.1007/s10549-011-1710-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-011-1710-0

Keywords

Navigation